Deep Bio Inc.
Al healthcare company with in-house expertise in deep learning and cancer pathology.
30 employees · est. 2015 · Seoul, Korea South
Exai Bio
Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cancer diagnosis.
22 employees · est. 2021 · Palo Alto, United States
Deep Bio Inc. is the older company (2015 vs 2021).
Side-by-Side Comparison
| Metric | Deep Bio Inc. | Exai Bio |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2021 |
| Headquarters | ||
| Headquarters | Seoul, Korea South | Palo Alto, United States |
| Employees | ||
| Employees | 30 | 22 |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Unknown |
| Total Funding | ||
| Total Funding | $5.60M | $138.96M |
| Funding Rounds | ||
| Funding Rounds | 2 | 2 |
| Services | ||
| Services | Not tracked yet | Cancer detection through next-generation RNA-based platform, Integration of novel RNA biomarkers with AI for clinical insights, Development and application of oncRNA technology |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare professionals, Medical researchers, Cancer treatment centers, Diagnostic laboratories, Biotech investors |
| Taxonomy | ||
| Taxonomy | Digital Pathology, Deep Learning Technology, Diagnostic Solutions, Pathologist Workflow Improvement, Computer-aided Diagnosis, Prostate Cancer Detection, Convolutional Neural Network, Biopsy Image Analysis | Liquid Biopsy, Cancer Detection, Cancer Diagnosis, Personalized Medicine, RNA Biology, Clinical Insights, Life Sciences, Precision Medicine, Diagnostics Technology, AI In Healthcare, Healthcare Innovation, Cancer Biology |
| Website | ||
| Website | deepbio.co.kr | exai.bio |
About Deep Bio Inc.
Deep Bio Inc. is a biotechnology startup headquartered in Korea South. Founded in 2015, the company has garnered attention for its innovative approach to addressing unmet medical needs. Deep Bio's flagship product, DeepDx®, leverages deep learning technology to offer pathologists fast, efficient, an...
About Exai Bio
Exai Bio, founded in 2021, is pioneering a next-generation liquid biopsy platform to support early detection and precise diagnosis of cancer, aligning with its mission to innovatively target cancer treatment. By leveraging proprietary RNA and artificial intelligence technology, the company promises...
We will tell you when either one moves
BounceWatch watches Deep Bio Inc. and Exai Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Deep Bio Inc. and Exai Bio — by email.
Frequently Asked Questions
Compare Deep Bio Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Deep Bio Inc. on 11 Sep 2024, and Exai Bio on 12 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.